SNY sanofi.com: Quick Liquidity Indicator

Sanofi efficiency is based on an academic approach to personnel and partnerships with biotech startups. The quick ratio demonstrates financial stability, where 0.65 becomes the new value of the indicator. The growth model relies on the mass release of patented drugs following costly trials. The environmental strategy includes the implementation of electric vehicles and the elimination of PVC in packaging.

Sanofi Aventis (SNY) - Intermediate Coverage Ratio from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for sanofi.com (SNY)

- share price and expert price forecast:

Stock Price Sanofi Aventis|SNY - Analyst Consensus Forecast

- company stock capitalization data:

Market Valuation Sanofi Aventis|SNY - Value Adjusted for Debt and Cash

- book capitalization indicators:

Book Value per Share Sanofi|SNY - Accounting Value of Company|Market Value to Book Value Ratio sanofi.com|SNY - Company Assets

- business debt structure and liquidity details:

- earnings and valuation multiples indicators:

SNY - Annual Net Income

Summary company analysis:Sanofi Aventis - SNY

Steady demand for Sanofi (SNY) vaccines and immunological drugs is reflected in the dynamics of the quick ratio. This indicator assesses the company's ability to instantaneously settle short-term liabilities using its most liquid assets. The calculation excludes inventory, accounting only for cash and accounts receivable. An optimal balance of this metric confirms the business's financial stability without sacrificing return on invested capital.

Competitors of Sanofi (SNY)